Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy

BACKGROUND: Addition of high-dose cytarabine (HDCA) to the conventional cyclophosphamide/total-body irradiation (CY/TBI) regimen significantly improved prognosis after cord blood transplantation (CBT) for adult acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). The efficacy of HDCA...

Descripción completa

Detalles Bibliográficos
Autores principales: Arai, Yasuyuki, Aoki, Kazunari, Takeda, June, Kondo, Tadakazu, Eto, Tetsuya, Ota, Shuichi, Hashimoto, Hisako, Fukuda, Takahiro, Ozawa, Yukiyasu, Kanda, Yoshinobu, Kato, Chiaki, Kurokawa, Mineo, Iwato, Koji, Onizuka, Makoto, Ichinohe, Tatsuo, Atsuta, Yoshiko, Takami, Akiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559384/
https://www.ncbi.nlm.nih.gov/pubmed/26337829
http://dx.doi.org/10.1186/s13045-015-0201-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559384/
https://www.ncbi.nlm.nih.gov/pubmed/26337829
http://dx.doi.org/10.1186/s13045-015-0201-x

Ejemplares similares